Genus (FRA:GBE) FCF Margin % : -2.52% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Genus FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genus's Free Cash Flow for the six months ended in Dec. 2023 was €-9.8 Mil. Genus's Revenue for the six months ended in Dec. 2023 was €387.2 Mil. Therefore, Genus's FCF Margin % for the quarter that ended in Dec. 2023 was -2.52%.

As of today, Genus's current FCF Yield % is 0.84%.

The historical rank and industry rank for Genus's FCF Margin % or its related term are showing as below:

FRA:GBE' s FCF Margin % Range Over the Past 10 Years
Min: -5.24 Med: 3.91 Max: 6.9
Current: 1.49

During the past 13 years, the highest FCF Margin % of Genus was 6.90%. The lowest was -5.24%. And the median was 3.91%.

FRA:GBE's FCF Margin % is ranked better than
81.26% of 1035 companies
in the Biotechnology industry
Industry Median: -149.8 vs FRA:GBE: 1.49

Genus FCF Margin % Historical Data

The historical data trend for Genus's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus FCF Margin % Chart

Genus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

1.04

5.51

5.87

-5.24

2.20

Genus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-5.76	-4.77	-0.91	5.42	-2.52

Competitive Comparison of Genus's FCF Margin %

For the Biotechnology subindustry, Genus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genus's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genus's FCF Margin % falls into.

Genus FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genus's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	17.714	/	803.779
	=	2.20 %

Genus's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-9.75	/	387.229
	=	-2.52 %

Genus FCF Margin % Related Terms

Thank you for viewing the detailed overview of Genus's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (FRA:GBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (FRA:GBE) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

GENSF:USA GNSl:UK GNS:UK

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus (FRA:GBE) Headlines

No Headlines